Greenway Medical Technologies (GWAY) Tops Q3 EPS by 4c

Greenway Medical Technologies (NYSE: GWAY) reported Q3 EPS of $0.08, $0.04 better than the analyst estimate of $0.04. Revenue for the quarter came in at $32.9 million versus the consensus estimate of $28.54 million.

For earnings history and earnings-related data on Greenway Medical Technologies (GWAY) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Etsy upgraded to buy at BofA on durable growth, buyback potential
• Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
• Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth